This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Takemura N, Saiura A, Koga R, Arita J, Yoshioka R, Ono Y, et al. Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg 2012; 397: 951-7. doi: 10.10007/s00423-012-0959-zTakemuraNSaiuraAKogaRAritaJYoshiokaROnoYLong-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resectionsLangenbecks Arch Surg2012397951710.10007/s00423-012-0959-zOpen DOISearch in Google Scholar
Sarel AI, Yelluri S. Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary? Arch Surg 2007; 142: 14349. doi: 10.1001/arch-surg.142.2.143SarelAIYelluriSGastric adenocarcinoma with distant metastasis: is gastrectomy necessary?Arch Surg20071421434910.1001/arch-surg.142.2.143Open DOISearch in Google Scholar
Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Transtuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-esophageal junction cancer (ToGa): a phase 3, open-label, randomised controlled trial. Lancet 2010; 37: 687-97. doi: 10.1016/s0140-6736(10)61121-xBangYJVanCutsem EFeyereislovaAChungHCShenLSawakiATranstuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-esophageal junction cancer (ToGa): a phase 3, open-label, randomised controlled trialLancet2010376879710.1016/s0140-6736(10)61121-xOpen DOISearch in Google Scholar
Kataoka K, Kinoshita T, Moehler M, Mauer M, Shitara K, Wagner AD, et al, On behalf of EORTIC GITCG Group and JCOG SCGS Group. Current management of liver metastases from gastric cancer: what is common practise? New challenge of EORTIC and JCOG. Gastric Cancer 2017; 20: 904-12. doi: 10.1007/s10120-017-0696-7KataokaKKinoshitaTMoehlerMMauerMShitaraKWagnerADet alOn behalf of EORTIC GITCG Group and JCOG SCGS Group. Current management of liver metastases from gastric cancer: what is common practise? New challenge of EORTIC and JCOGGastric Cancer2017209041210.1007/s10120-017-0696-7Open DOISearch in Google Scholar
Kinoshita T, Kinoshita T, Saiua A, Esaki M, Sakamoto H, Yamanaka T. Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg 2015; 102: 102-7. doi: 10.1002/ bjs.9684KinoshitaTKinoshitaTSaiuaAEsakiMSakamotoHYamanakaTMulticentre analysis of long-term outcome after surgical resection for gastric cancer liver metastasesBr J Surg2015102102710.1002/bjs.9684Open DOISearch in Google Scholar
Zacherl J, Zacherl M, Scheuba C, Steininger R, Wenzel E, Mühlbacher Jakesz R, et al. Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointestinal Surg 2002; 6: 682-9. doi: 10.1016/ s1091-255x(01)00075-0ZacherlJZacherlMScheubaCSteiningerRWenzelEMühlbacherJakesz RAnalysis of hepatic resection of metastasis originating from gastric adenocarcinomaJ Gastrointestinal Surg20026682910.1016/s1091-255x(01)00075-0Open DOISearch in Google Scholar
Schildberg CW, Croner R, Merkel S, Schellerer V, Müller V, Yedibela S, et al. Outcome of operative therapy of hepatic metastatic stomach carcinoma: A retrospective analysis. World J Surg 2012; 36: 872-8. doi: 10.1007/s00268-012-1492-5SchildbergCWCronerRMerkelSSchellererVMüllerVYedibelaSOutcome of operative therapy of hepatic metastatic stomach carcinoma: A retrospective analysisWorld J Surg201236872810.1007/s00268-012-1492-522354489Open DOISearch in Google Scholar
Sakamoto Y, Sano T, Shimada K, Esaki M, Saka M, Fukagawa T, et al. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 2007; 95: 534-9. doi: 10.1002/jso.20739SakamotoYSanoTShimadaKEsakiMSakaMFukagawaTFavorable indications for hepatectomy in patients with liver metastasis from gastric cancerJ Surg Oncol200795534910.1002/jso.2073917219383Open DOISearch in Google Scholar
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-96. doi: 10.1097/SLA.0b013e3181b13ca2ClavienPABarkunJde OliveiraMLVautheyJNDindoDSchulickRDThe Clavien-Dindo classification of surgical complications: five-year experienceAnn Surg20092501879610.1097/SLA.0b013e3181b13ca219638912Open DOISearch in Google Scholar
Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Surg 2005; 12: 351-5. doi: 10.1007/s00534-005-0999-7StrasbergSMNomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 systemJ Hepatobiliary Surg200512351510.1007/s00534-005-0999-716258801Open DOISearch in Google Scholar
Jiu-Yang Liu, Chun-Wei Peng, Xiao-Jun Yang, Chao-Qun Huang, Yan Li. The prognosis role of AJCC/UICC 8th Edition staging system in gastric cancer, a retrospective analysis. Am J Transl Res 2018; 10: 292-303. PMID: 29423014LiuJiu-YangPengChun-WeiYangXiao-JunHuangChao-QunLiYanThe prognosis role of AJCC/UICC 8th Edition staging system in gastric cancer, a retrospective analysisAm J Transl Res201810292303PMID: 29423014Search in Google Scholar
Tatsubayashi T, Tanizawa Y, Miki Y, Tokunaga M, Bando E, Kawamura T, et al. Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging. Gastric Cancer 2017; 20: 387-93. doi: 10.1007/s10120-016-0611-7TatsubayashiTTanizawaYMikiYTokunagaMBandoEKawamuraTTreatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imagingGastric Cancer2017203879310.1007/s10120-016-0611-7Open DOISearch in Google Scholar
Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004; 22: 2069-77. doi: 10.1200/JCO.2004.08.026HartgrinkHHvan deVelde CJPutterHBonenkampJJKleinKranenbarg ESongunIExtended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trialJ Clin Oncol20042220697710.1200/JCO.2004.08.026Open DOISearch in Google Scholar
Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. The surgical cooperative group. Lancet 1996; 347: 995-9. doi: 10.1016/ s0140-6736(96)90144-0CuschieriAFayersPFieldingJCravenJBancewiczJJoypaulVPostoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. The surgical cooperative groupLancet1996347995910.1016/s0140-6736(96)90144-0Open DOISearch in Google Scholar
Jung JO, Nienhüser H, Schleussner N, Schmidt T. Oligometastatic gastroesophageal adenocarcinoma: molecular pathophysiology and current therapeutic approach. Inter J Mol Sciences 2020; 21: 3-24. doi: 10.3390/ ijms21030951JungJONienhüserHSchleussnerNSchmidtTOligometastatic gastroesophageal adenocarcinoma: molecular pathophysiology and current therapeutic approachInter J Mol Sciences20202132410.3390/ijms21030951Open DOISearch in Google Scholar
Oki E, Tokunaga S, Emi Y, Kusumoto T, Yamamoto M, Fukuzawa K, et al. Kyushu Study Group of Clinical Cancer. Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302). Gastric Cancer 2016; 19: 968-76. doi: 10.1007/s10120-015-0530-zOkiETokunagaSEmiYKusumotoTYamamotoMFukuzawaKKyushu Study Group of Clinical Cancer. Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302)Gastric Cancer2016199687610.1007/s10120-015-0530-zOpen DOISearch in Google Scholar
Fujitani K, Yang HK, Mizusawa J, Kim YW, Terashima M, Han SU, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet 2016; 17: 309-18. doi: 10.1016/S1470-2045(15)00553-7FujitaniKYangHKMizusawaJKimYWTerashimaMHanSUGastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trialLancet2016173091810.1016/S1470-2045(15)00553-7Open DOISearch in Google Scholar
Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41-55. 10.1093/ biomet/70.1.41RosenbaumPRRubinDBThe central role of the propensity score in observational studies for causal effectsBiometrika198370415510.1093/biomet/70.1.41Open DOISearch in Google Scholar
Li M. Using the propensity score method to estimate causal effects: a review and practical guide. Organ Res Methods 2012; 15: 1-39. doi: 10.1177/1094428112447816 http://orm.sagepub.comLiMUsing the propensity score method to estimate causal effects: a review and practical guideOrgan Res Methods20121513910.1177/1094428112447816http://orm.sagepub.comOpen DOISearch in Google Scholar
Makino H, Kunisaki C, Izumisawa Y, Tokuhisa M, Oshima T, Nagano Y, et al. Indication for hepatiec resection in treatment of liver metastasis from gastric cancer. Anticancer Res 2010; 30: 2367-76. doi: 10.1016/S1470-2045(15)00553-7MakinoHKunisakiCIzumisawaYTokuhisaMOshimaTNaganoYIndication for hepatiec resection in treatment of liver metastasis from gastric cancerAnticancer Res20103023677610.1016/S1470-2045(15)00553-7Open DOISearch in Google Scholar
Fujitani K, Yang HK, Mizusawa J, Terashima M, Han SU, Iwasaki Y, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, ran-domised controlled trial. Lancet Oncol 2016; 17: 1-10. doi: 10.1016/S1470-2045(15)00553-7FujitaniKYangHKMizusawaJTerashimaMHanSUIwasakiYGastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, ran-domised controlled trialLancet Oncol20161711010.1016/S1470-2045(15)00553-7Open DOISearch in Google Scholar
Ministrini S, Bencivenga M, Solaini L, Cipollari C, Sofia S, Marino E, et al. Stage IV gastric cancer: The surgical perspective of the Italian Research Group on Gastric Cancer. Cancers 2020; 12: 1-14. doi: 10.3390/cancers12010158MinistriniSBencivengaMSolainiLCipollariCSofiaSMarinoEStage IV gastric cancer: The surgical perspective of the Italian Research Group on Gastric CancerCancers20201211410.3390/cancers12010158701653631936512Open DOISearch in Google Scholar
